Business
Bio Spectrum
"India needs to deepen capabilities and ensure consistent execution across the clinical research ecosystem
The Indian Society for Clinical Research (ISCR), an association of clinical research professionals, hosted its 19th Annual Conference in Delhi on February 13-14, 2026, to explore how digital innovation, global collaboration and regulatory excellence are shaping the future of patient-centric clinical research in India.
4 min |
April 2026
Bio Spectrum
New England Biolabs opens subsidiary in Bengaluru
US-based New England Biolabs (NEB), a world leader in the production of reagents for the life science industry, is extending its global subsidiary network with the opening of New England Biolabs India Pvt Ltd (NEB India) at Phoenix Asia Towers in Bengaluru, Karnataka.
1 min |
April 2026
Bio Spectrum
Bruker advances Functional Proteomics 2.0 with timsOmni Mass Spectrometry Proteoform Analysis
US-based Bruker Corporation has announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni mass spectrometer to enable disease researchers to move beyond canonical protein lists toward biologically or pathologically functional proteoforms and PTM-resolved peptide variants.
1 min |
April 2026
Bio Spectrum
Global partners launch initiatives to address extreme heat in South Asia
The World Health Organization (WHO)-World Meteorological Organization (WMO) Climate and Health Joint Programme, The Rockefeller Foundation, and Wellcome have announced new regional efforts to protect South Asians from extreme heat, a rapidly escalating threat to human health and economic stability in the subcontinent.
1 min |
April 2026
Bio Spectrum
NIPER, Rae Bareli inks MoU with Boehringer Ingelheim India
In a bid to promote pharmaceutical education and research in India, a Memorandum of Understanding (MoU) has been signed between the Rae Bareli-based National Institute of Pharmaceutical Education and Research (NIPER) and Boehringer Ingelheim India.
1 min |
April 2026
Bio Spectrum
India and Brazil sign MoU to strengthen cooperation in pharma and medical products regulation
India and Brazil have signed a Memorandum of Understanding (MoU) to strengthen bilateral cooperation in the field of regulation of pharmaceutical medical products.
1 min |
April 2026
Bio Spectrum
'Trust is fundamental to any meaningful use of AI in healthcare'
With the aim of fostering dialogue around the future of healthcare innovation, Apollo Hospitals organised the International Health Dialogue (IHD) 2026 in Hyderabad.
2 min |
April 2026
Bio Spectrum
“India is well positioned to accelerate translation from lab research to scalable production”
Cytiva has strengthened its India presence with a significant investment in 30,000 sq. ft.
4 min |
April 2026
Bio Spectrum
Beckman Coulter accelerates AI-ready laboratory automation
Beckman Coulter Life Sciences and Automata have announced a strategic partnership that integrates Beckman Coulter Life Sciences liquid handling, genomic and cell analysis technologies with Automata's AI-ready automation platform to enable faster, more consistent and more scalable experimentation for research organisations.
1 min |
April 2026
Bio Spectrum
Healthcare cybersecurity regulations in India are still evolving
As healthcare and pharmaceutical ecosystems become increasingly digital and interconnected, cybersecurity is emerging as a critical priority for the sector. From ransomware attacks on pharmaceutical manufacturing facilities to vulnerabilities in connected medical devices and hospital systems, cyber threats are growing both in scale and sophistication.
4 min |
April 2026
Bio Spectrum
"India is well positioned to emerge as a major market and a manufacturing hub for monoclonal antibodies"
Ahmedabad-based biopharmaceutical company Kashiv BioSciences has recently secured funds for advancing its world-class infrastructure, to pursue research, development, and manufacturing strategy in both US and India.
5 min |
April 2026
Bio Spectrum
US FDA accelerates development of therapies for ultra-rare diseases
The US Food and Drug Administration (FDA) has issued draft guidance for sponsors seeking approval for targeted individualised therapies by generating substantial evidence of effectiveness and safety when randomised controlled trials are not feasible due to small patient populations.
1 min |
April 2026
Bio Spectrum
Meenal Gauri steps in as MD at Boehringer Ingelheim India
Boehringer Ingelheim has announced that Meenal Gauri has been appointed as Managing Director for India. In this role, she will assume responsibility for the company's businesses in India, Bangladesh, Nepal, Sri Lanka, and the Maldives.
1 min |
April 2026
Bio Spectrum
MSD names Brecht Vanneste as Managing Director of India
MSD (known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada) has announced the appointment of Brecht Vanneste as Managing Director (MD) of MSD in India, effective March 1, 2026. He will be based in Mumbai.
1 min |
April 2026
Bio Spectrum
Africa CDC and FHI 360 sign MoU to strengthen health security
The Africa Centres for Disease Control and Prevention (Africa CDC) and FHI 360 have signed a Memorandum of Understanding (MoU) to strengthen collaboration in advancing health security, workforce development, and resilient public health systems across Africa.
1 min |
April 2026
Bio Spectrum
PAHO & WHO sign agreement to strengthen hospital resilience
WHO's Regional Office for the Eastern Mediterranean (EMRO) and the Pan American Health Organization (PAHO) have signed a Memorandum of Arrangement to strengthen collaboration on making hospitals safer and better prepared for health emergencies and disasters.
1 min |
April 2026
Bio Spectrum
Vaccines and Immunisation 2.0
India firmly established its position as a global leader in vaccine manufacturing and innovation during COVID-19. After addressing the pressing global vaccine demands back then, India continued to strengthen its R&D capabilities and diversify its vaccine development strategies, while expanding immunisation programmes to tackle deadly diseases.
5 min |
April 2026
Bio Spectrum
Thermo Fisher announces launch of TacroType Pharmacogenetic Test
US-based Thermo Fisher Scientific, the world leader in serving science, has announced the launch of the TacroType Pharmacogenetic Test, a new laboratory developed test designed to help inform clinicians on dosing tacrolimus, a commonly prescribed immunosuppressive drug for transplant recipients to lower the risk of rejection.
1 min |
April 2026
Bio Spectrum
Preventing Cancer with HPV vaccines
A three-month HPV vaccination drive by the Ministry of Health and Family Welfare for adolescent girls was launched on February 28 with much fanfare. The free, World Health Organisation (WHO)approved single-dose Gardasil-4 vaccine is being touted as a game changer in the long-term fight against cervical cancer. However, the initiative may face initial hurdles, and a stronger awareness campaign will be essential to ensure that more girls receive the vaccine.
6 min |
April 2026
Bio Spectrum
How India's Life Sciences Boom Is Creating a New Risk Economy
India's life sciences boom is shifting from a pure growth story to a test of risk architecture. As companies expand into regulated global markets, they import stricter oversight and liability exposuremaking governance, compliance, and resilience as critical as scale in defining the sector's next winners.
5 min |
April 2026
Bio Spectrum
How Global Alliances are Powering India's AI-Healthcare Innovation
The rapid convergence of artificial intelligence (AI) with healthcare is ushering in a new era of cross-border innovation, with India emerging as a key global collaborator. This trend was well highlighted during the India AI Impact Summit 2026, held from 16–20 February 2026 at Bharat Mandapam in New Delhi. Being described as the first major global AI summit hosted in the Global South, the event witnessed participation of more than 100 countries, with many either exploring new partnerships with India, or strengthening the existing ties. Let's take a look at how AI-based healthcare innovation is building up globally.
4 min |
April 2026
Bio Spectrum
"India should invest more aggressively in genomic surveillance to stay ahead of emerging encephalitis threats”
India has made notable strides in tackling encephalitis over the past decade, with mortality from Acute Encephalitis Syndrome (AES) falling significantly and Japanese Encephalitis (JE) cases declining in several high-burden states.
4 min |
April 2026
Bio Spectrum
Can India's CDMOS Lead the Next Biopharma Wave?
India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).
8 min |
March 2026
Bio Spectrum
Telangana turns catalyst for innovation
Telangana is at a pivotal moment in its journey as a global life sciences hub.
6 min |
March 2026
Bio Spectrum
Is AI the New Weapon in the Fight to End TB?
A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).
2 min |
March 2026
Bio Spectrum
ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India
US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.
1 min |
March 2026
Bio Spectrum
Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy
Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.
5 min |
March 2026
Bio Spectrum
"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"
Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.
5 min |
March 2026
Bio Spectrum
Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer
Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.
1 min |
March 2026
Bio Spectrum
Haleon ropes in Kedar Lele as President for India Subcontinent
Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.
1 min |